Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-24
1992-03-24
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 83, 514 88, 514 89, 514 91, 514255, 5142278, 5142315, 514422, 514549, 514824, 514320, 544110, 544147, 544 587, 544337, 544374, 546 22, 546206, 548112, 548517, 549222, 549264, A61K 31365, C07D30930
Patent
active
050989316
ABSTRACT:
Novel HMG-CoA reductase inhibitors are useful as antihypercholesterolemic agents and are represented by structural formulae (I) and (II): ##STR1##
REFERENCES:
patent: 4611067 (1986-09-01), Volante et al.
patent: 4866090 (1989-09-01), Hoffman et al.
patent: 4921974 (1990-05-01), Duggan et al.
patent: 4963538 (1990-10-01), Duggan et al.
Duggan Mark E.
Halczenko Wasyl
Hartman George D.
DiPrima Joseph F.
Merck & Co. , Inc.
Raymond Richard L.
Russell Mark W.
Winokur Melvin
LandOfFree
7-substituted HMG-CoA reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-substituted HMG-CoA reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-substituted HMG-CoA reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010653